U-Blot® Teprotumumab Polyclonal AntibodyCat. No. WP26413Request quote
Size: 50μL/100μL
Polyclonal antibodies are produced from the serum of immunized animals and target multiple epitopes on antigens. They deliver robust binding signals, high experimental tolerance, short production cycles and excellent cost-effectiveness. They are ideal for preliminary target verification and short-term research applications.
U-Blot® Teprotumumab Polyclonal AntibodyCat. No. WP26413
U-Blot® Sacituzumab Polyclonal AntibodyCat. No. WP26412
U-Blot® Inebilizumab Polyclonal AntibodyCat. No. WP26411
U-Blot® Satralizumab Polyclonal AntibodyCat. No. WP26410
U-Blot® Tafasitamab Polyclonal AntibodyCat. No. WP26409
U-Blot® Belantamab Polyclonal AntibodyCat. No. WP26408
U-Blot® Odesivimab Polyclonal AntibodyCat. No. WP26407
U-Blot® Maftivimab Polyclonal AntibodyCat. No. WP26406
U-Blot® Atoltivimab Polyclonal AntibodyCat. No. WP26405
U-Blot® Naxitamab Polyclonal AntibodyCat. No. WP26404
U-Blot® Margetuximab Polyclonal AntibodyCat. No. WP26403
U-Blot® Ansuvimab Polyclonal AntibodyCat. No. WP26402